N

Nabsys Tech Stack

Long-read DNA mapping platform for structural variant detection

Biotechnology Research Providence, RI 11–50 employees Privately Held

Nabsys develops a nanodetector-based genome mapping platform (OhmX) designed to identify structural variants down to 300 bp—a capability gap between optical imaging and next-generation sequencing. The stack reveals a hardware-software hybrid: Python and C++ drive analysis pipelines (Flask, SQL, Kubernetes), while the core IP is solid-state nanodetection hardware. Active projects span chip design iteration with semiconductor partners, cancer-focused assay development, and algorithm validation against competing technologies, signaling a product still in clinical/commercial validation rather than mature deployment.

Tech Stack 16 technologies

Core StackPython C++ Angular jQuery TypeScript Flask Kubernetes Docker Illumina PacBio macOS Windows CSS HTML5 SQL REST

What Nabsys Is Building

◆Challenges

Advancing electronic genome mapping technology
Enhancing informatics pipeline efficacy
Expanding application to cancer and rare disease
Expanding utility of electronic genome mapping
Improving sv detection methods
Validating new protocols
Strengthening it infrastructure
Improving data security posture
Compliance remediation
Integration of bioinformatics applications

▲Active Projects

Nanodetector chip product development
Automated run protocol optimization
New detector design with semiconductor foundry
Enhance nabsys analytics platform methods
Develop custom methods for cancer use cases
Evaluate sv calling algorithm efficacy
Demonstrate utility of electronic genome mapping across customer segments
Adapt and develop protocols to expand egm capabilities
Evaluate sv calling algorithms across orthogonal technologies
Customer-facing pipelines and applications

Hiring Activity

Minimal9 roles · 1 in 30d

Department

Engineering

4

Manufacturing

2

Data

1

Ops

1

Research

1

Seniority

Senior

4

Junior

2

Mid

2

Director

1

Company intelligence

Find more companies like Nabsys by tech stack, pain points and active projects

Get started free

About Nabsys

Nabsys is a biotechnology company focused on structural variant detection in genomics. The OhmX platform uses solid-state nanodetectors to read long DNA molecules and map chromosomal rearrangements, balanced and unbalanced, at high resolution without fluorescent labels. The company targets research institutions and clinical labs seeking cost-effective, rapid whole-genome structural variant analysis. At 11–50 employees with a 30-person engineering-to-manufacturing ratio, Nabsys operates as a hardware-software vendor in a space dominated by optical and sequencing incumbents. Current initiatives center on expanding application scope (cancer, rare disease), strengthening IT and data security infrastructure, and validating detection algorithms across external benchmarks.

HeadquartersProvidence, RI

Company Size11–50 employees

Hiring MarketsUnited States

Frequently Asked Questions

What is Nabsys's core technology?

Nabsys develops electronic genome mapping (EGM) using solid-state nanodetectors to detect structural variants as small as 300 bp across the whole genome without fluorescent imaging, offered through the OhmX platform.

What tech stack does Nabsys use?

Nabsys uses Python, C++, Flask, SQL, Kubernetes, and Docker for the analytics and infrastructure layer; TypeScript, Angular, and jQuery for frontend; and integrates with Illumina and PacBio sequencing platforms.